Department of Head and Neck Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Cancer Rep (Hoboken). 2022 Oct;5(10):e1671. doi: 10.1002/cnr2.1671. Epub 2022 Jul 21.
Intractable nasopharyngeal hemorrhage is a severe complication with high mortality rate in patients with radiation therapy (RT) for nasopharyngeal carcinoma (NPC) that requires emergency treatment. Quite a few of them combine with tumor recurrence. Treatment planning for these patients is extremely difficult for oncologists, and effective treatments are lacking.
A 42-year-old man had a history of recurrent NPC that was treated with 2 cycles of chemoradiotherapies from 2017 to 2019. Five months after the second round of chemoradiotherapy, an episode of massive nasal bleeding occurred. As positron emission tomography (PET) scan revealed tumor recurrence in the left wall of nasopharynx, superselective embolization and subsequent intra-arterial infusion (IA, 4 times of cisplatin 60 mg + fluorouracil 1.0 g) were performed to stop bleeding and achieve tumor control. To date, the disease-free survival time has been over 1 year. No tumor recurrence or rebleeding is found except for alopecia on the left side.
Interventional radiology is important and effective in the treatment of recurrent NPC for both massive nasal bleeding and tumor control. However, the unique complication of unilateral alopecia should not be ignored.
对于接受放射治疗(RT)的鼻咽癌(NPC)患者,难治性鼻咽大出血是一种严重的并发症,死亡率很高,需要紧急治疗。其中相当一部分患者还合并肿瘤复发。对于肿瘤学家来说,这些患者的治疗计划极具挑战性,且缺乏有效的治疗方法。
一名 42 岁男性曾因复发性 NPC 接受了 2 周期的放化疗治疗,时间为 2017 年至 2019 年。第二次放化疗后 5 个月,他出现了一次大出血。由于正电子发射断层扫描(PET)显示鼻咽左壁肿瘤复发,因此进行了超选择性栓塞,随后进行了动脉内输注(IA,4 次顺铂 60mg+氟尿嘧啶 1.0g)以止血和控制肿瘤。迄今为止,无病生存时间已超过 1 年。除了左侧脱发外,未发现肿瘤复发或再出血。
介入放射学在治疗复发性 NPC 引起的大出血和肿瘤控制方面非常重要且有效。然而,不应忽视单侧脱发这一独特的并发症。